Cancer Vaccines (Breast/Ovarian)

Theratope Data Presented at Paris Conference

Published in Women's Health Weekly, February 26th, 1996

Biomira Inc., Edmonton, Alberta, Canada, announced the results of Theratope therapeutic cancer vaccine clinical trials presented at the Sixth International Congress on Anti-Cancer Treatment, held in Paris, France, February 6-9, 1996.

Investigators reported an apparent survival advantage for patients with metastatic cancer of the breast or ovary who developed a strong vaccine-induced antibody response against Theratope vaccine. These patients showed a statistically significant improvement in survival over patients who did not develop a strong immune response to the Theratope vaccine treatment, suggesting there is an association between antibody production against the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (1996-02-26)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry